Fredun Pharmaceuticals Limited (BOM:539730)
India flag India · Delayed Price · Currency is INR
1,453.35
-94.40 (-6.10%)
At close: Aug 17, 2026

Fredun Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
7,4386,3554,5383,4822,7472,245
Revenue Growth
49.70%40.03%30.35%26.75%22.37%67.74%
Gross Profit
1,8231,6341,039724.71555.79401.99
Operating Income
961.95826.38486.21342.99251.65117.41
Net Income
389.87326.21197.39156.23108.0763.35
Earnings Per Share
23.4820.4114.1711.228.045.09
EPS Growth
38.79%43.98%26.34%39.48%58.14%202.19%

Revenue by Geography

Fiscal YearFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
export
1,070761.81777.14620.31736.09
India
5,2643,7652,6892,1231,481
Total
6,3334,5273,4662,7432,217

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
649.27649.2751.7321.2134.0521.04
Total Debt
2,4222,4221,6841,055865.47606.59
Net Cash (Debt)
-1,772-1,772-1,632-1,034-831.41-585.54
Net Cash Growth
------
Net Cash Per Share
-106.73-110.88-117.20-74.24-61.89-47.01

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-119.02-165.98-4.39-144.09-23.8
Capital Expenditures
--735.91-61.06-76.39-94.95-42.86
Free Cash Flow
--616.89-227.04-80.78-239.03-66.66
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
24.52%25.71%22.90%20.82%20.23%17.91%
Operating Margin
12.93%13.00%10.71%9.85%9.16%5.23%
Pretax Margin
7.87%7.40%6.06%6.16%6.37%3.83%
Profit Margin
5.24%5.13%4.35%4.49%3.93%2.82%
FCF Margin
--9.71%-5.00%-2.32%-8.70%-2.97%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
0.2330.2330.2330.2330.2330.233
Dividend Per Share Growth
0%0%0%0%0%0%
Dividend Yield
0.01%0.04%0.10%0.10%0.09%0.08%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
61.9024.7515.9221.5833.0564.04
PS Ratio
3.231.270.690.971.301.81